Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey

BACKGROUND: The Icatibant Outcome Survey (IOS; NCT01034969) is a Shire‐sponsored, international, observational study monitoring the safety and effectiveness of icatibant, a bradykinin B2 receptor antagonist approved for the acute treatment of adults with hereditary angioedema with C1 inhibitor defic...

Descripción completa

Detalles Bibliográficos
Autores principales: Maurer, M., Bork, K., Martinez‐Saguer, I., Aygören‐Pürsün, E., Botha, J., Andresen, I., Magerl, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Autoimmune Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587717/
https://www.ncbi.nlm.nih.gov/pubmed/30176179
http://dx.doi.org/10.1111/jdv.15232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587717/
https://www.ncbi.nlm.nih.gov/pubmed/30176179
http://dx.doi.org/10.1111/jdv.15232

Ejemplares similares